AIFA. Report regionali sul consumo dei farmaci in Italia – anno 2024
21 aprile 2026
Leggi
AIFA. Dalle terapie a taglia unica alle cure su misura: la rivoluzione della medicina di precisione
17 aprile 2026
Leggi
Age- and sex-specific trends in dementia mortality among people with and without diabetes: a multi-country population-based analysis
Mehta K, Morton JI, Chen L, et al.
Diabetologia. Pub. online 21 Apr 2026.
Leggi
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
Wilmot EG, Moore P, Sathyapalan T, et al.
Lancet Diabetes Endocrinol. Pub. online 23 Apr 2026.
Leggi
Efficacy, safety and PK of once-daily oral semaglutide 25 mg for obesity with and without type 2 diabetes in comparison with subcutaneous semaglutide 2.4 mg: a model-informed drug development approach
Overgaard RV, Birkhan O, Rathor N, et al.
Diabetes Obes Metab. Pub. online 23 Apr 2026.
Leggi
The role of continuous glucose monitoring for diagnosis of gestational diabetes: exploring the potential
Crowley M, Newman C, Dunne FP
BMC Med. Pub. online 21 Apr 2026.
Leggi
Outcomes with finerenone by baseline treatment goals in type 2 diabetes and chronic kidney disease: a FIDELITY analysis
Neves JS, Leite AR, Vasques-Nóvoa F, et al.
Diabetes Obes Metab. Pub. online 24 Apr 2026.
Leggi
Oral glucose absorption is enhanced in early metabolic dysfunction-associated steatotic liver disease
Tricò D, Wu T, Cimbalo N, et al.
Diabetologia. Pub. online 21 Apr 2026.
Leggi
Gene therapy and gene editing in type 1 diabetes: CRISPR-based β-cell replacement and treg immune modulation approaches
Lin TM, Chang HF, Lin TC, et al.
Diabetes Obes Metab. Pub. online 23 Apr 2026.
Leggi
Obstructive sleep apnoea is associated with accelerated progression of diabetic kidney disease
Nielsen S, Thomsen MB, Nyvad J, et al.
Diabet Med. Pub. online 23 Apr 2026.
Leggi